482 results on '"Gilbert, Edward M"'
Search Results
102. Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients
103. Rationale and Design of the Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation (THE BALANCE) Study
104. Discovery and Validation of Novel Genes in Cardiac Remodeling
105. Transcriptional Profiles of Reverse Remodeling
106. Effects of the 2006 U.S. thoracic organ allocation change: Analysis of local impact on organ procurement and heart transplantation
107. CAN ECHOCARDIOGRAPHIC EVALUATION OF CARDIOPULMONARY HEMODYNAMICS REPLACE RIGHT HEART CATHETERIZATION IN END-STAGE HEART FAILURE PATIENTS AWAITING TRANSPLANTATION?
108. Utility of Virtual Crossmatch in Sensitized Patients Awaiting Heart Transplantation
109. Effects of β-Blocker Titration on Glucose Homeostasis in Heart Failure
110. Tuberculosis in a Solid-organ Transplant Recipient: Modern-day Implications
111. A Clinical Correlation Study of Severity of Antibody-mediated Rejection and Cardiovascular Mortality in Heart Transplantation
112. Results of A Multicenter, Randomized, Double Blind, Double Dummy, Parallel Group Study to Compare Effects of Coreg CR and Coreg IR on Left Ventricular End Systolic Volume Index in Subjects with Stable Chronic Heart Failure (The COMPARE Trial) (10/7/08)
113. Assessment of Response to Carvedilol in Heart Failure Patients Utilizing Echocardiographic Measurements of Systolic and Diastolic Parameters
114. Early Screening for Antibody-mediated Rejection in Heart Transplant Recipients
115. Carvedilol Exhibits No Tolerance to α1-Receptor Blockade in Class C Heart Failure Subjects
116. Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure
117. Effect of Reversible Pulmonary Hypertension on Outcomes After Heart Transplantation
118. Multivariate Predictors of Heart Transplantation Outcomes in the Era of Chronic Mechanical Circulatory Support
119. Heart Failure in Community Practice: Relationship to Age and Sex in a ?-Blocker Registry
120. Impact of Repetitive Episodes of Antibody-mediated or Cellular Rejection on Cardiovascular Mortality in Cardiac Transplant Recipients: Defining Rejection Patterns
121. Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients
122. Percutaneous Coronary Interventions With Stents in Cardiac Transplant Recipients
123. The Effect of β-Blocker Use on Cyclosporine Level in Cardiac Transplant Recipients
124. Utility of Histologic Parameters in Screening for Antibody-Mediated Rejection of the Cardiac Allograft: A Study of 3,170 Biopsies
125. Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry
126. Beta-blockers in patients with left ventricular ejection fraction >40%: results from a community-based registry
127. Titration, tolerability, and results of beta-blocker therapy for heart failure in the community: Findings of a community-based registry
128. Improved ventilatory response at peak exercise despite no change in peak oxygen consumption with chronic beta-blockade in heart failure patients
129. Carvedilol initiation by community physicians in COHORE: comparison with U.S. carvedilol trials and compassionate use protocols
130. Enhanced monocyte tissue factor procoagulant activity in heart failure is associated with apoptosis
131. Carvedilol in the failing heart
132. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs
133. The role of third-generation beta-blocking agents in chronic heart failure
134. Combined Oral Positive Inotropic and Beta-Blocker Therapy for Treatment of Refractory Class IV Heart Failure
135. Editor's Mailbox
136. Effects of Carvedilol on Right Ventricular Function in Chronic Heart Failure
137. Safety and efficacy of carvedilol in severe heart failure
138. Comparative Hemodynamic, Left Ventricular Functional, and Antiadrenergic Effects of Chronic Treatment With Metoprolol Versus Carvedilol in the Failing Heart
139. Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure
140. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy
141. Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
142. Role of beta-adrenergic receptor downregulation in the peak exercise response in patients with heart failure due to idiopathic dilated cardiomyopathy
143. Pharmacologic and Hemodynamic Effects of Combined β-Agonist Stimulation and Phosphodiesterase Inhibition in the Failing Human Heart
144. Reply
145. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
146. Left ventricular mass increases during cardiac allograft vascular rejection
147. AUGMENTED DIGOXIN CONCENTRATIONS WITH CARVEDILOL DOSING IN MILD-MODERATE HEART FAILURE
148. Beta-Adrenergic Receptors, from Their Discovery and Characterization through Their Manipulation to Beneficial Clinical Application.
149. Allograft Rejection in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
150. Double-Blind Placebo-Controlled Comparison of Enoximone and Dobutamine Infusions in Patients With Moderate to Severe Chronic Heart Failure.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.